Paediatric Hematologic Research Group
51 – 60 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs
- Contribution to journal › Scientific review
-
Mark
Cyclin A Is a Proliferative Marker with Good Prognostic Value in Node-Negative Breast Cancer.
(2009) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18. p.2501-2506
- Contribution to journal › Article
-
Mark
Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
- Contribution to journal › Article
-
Mark
Successful thrombolysis of neonatal bilateral renal vein thrombosis originating in the IVC.
- Contribution to journal › Article
- 2008
-
Mark
Venous access - why such diverse experiences of central venous lines?
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.96-96
- Contribution to journal › Published meeting abstract
-
Mark
Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors
- Contribution to journal › Article
-
Mark
Management of delivery and neonatal period
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.5-5
- Contribution to journal › Published meeting abstract
-
Mark
Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG)
- Contribution to journal › Article
-
Mark
Quality of life in haemophilia carriers - preliminary results of the ESCHQoL study
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.150-150
- Contribution to journal › Published meeting abstract
-
Mark
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
- Contribution to journal › Article
